Natalia López Andrés | Traslational Cardiology | Best Researcher Award

Posted on by Academic achievements

Dr. Natalia López Andrés | Traslational Cardiology  | Best Researcher Award

Dr. at Navarrabiomed-Fundación Miguel Servet, Spain

Dr. Natalia López-Andrés (NLA) graduated in Biological Sciences at Universidad de Navarra (Spain). In 2006, she was awarded a PhD in Cardiovascular Research (University of Navarra, Spain). She has previously held a Postdoctoral position at the Division of Cardiovascular Sciences in the Centre for Applied Medical Research (Pamplona, 2006-2008) to study heart failure within a multidisciplinary group. In 2008, NLA joined the research unit U961 at the INSERM (Nancy, France) where she was relocated as Research Associate until 2013. She developed a vast expertise studying the mechanisms of action, diagnosis and therapeutics of cardiovascular stiffness-fibrosis and hypercoagulability.

 

Professional Profiles

Scopus Profile

ORCID

Professional Situation🏢

Current Position

Position: Researcher
Start Date: 2022
Institution: Navarrabiomed
Keywords: Molecular mechanisms of disease, Laboratory animals, Cell culture, Tissue culture

Previous Professional Situation 🧑‍🔬

Period: 2008 – 2012
Position: Post-doctoral Student
Institution: INSERM (France)

Period: 2006 – 2008
Position: Post-doctoral Student
Institution: Centro de Investigación Biomédica Aplicada

Academic Training 🎓

Degree: PhD in Cardiovascular Research
University: University of Navarra
Year: 2006

Degree: Bachelor in Biology, Option Biological Health
University: University of Navarra
Year: 2001

Curriculum Vitae Summary

Dr. Natalia López-Andrés (NLA) graduated in Biological Sciences at Universidad de Navarra, Spain. In 2006, she was awarded a PhD in Cardiovascular Research (University of Navarra, Spain). She previously held a Postdoctoral position at the Division of Cardiovascular Sciences in the Centre for Applied Medical Research (Pamplona, 2006-2008), focusing on heart failure within a multidisciplinary group.

In 2008, NLA joined the research unit U961 at INSERM (Nancy, France), where she served as a Research Associate until 2013. She developed vast expertise in studying the mechanisms of action, diagnosis, and therapeutics of cardiovascular stiffness-fibrosis and hypercoagulability.

In 2014, she received a competitive Research Fellowship ‘Miguel Servet’ from the ISCIII-Spanish Government. This fellowship allowed her to independently establish and lead a multidisciplinary Cardiovascular Translational Research Group at Navarrabiomed-FMS (Spain). Her primary research interest is the pathogenesis of heart valve disease (HVD), while expanding her expertise in myocardial remodeling underlying other forms of cardiovascular disease and chronic kidney disease. Over the past 10 years, NLA has become an internationally acknowledged expert studying the role of the Aldosterone/mineralocorticoid receptor (Aldo/MR) axis, galectin-3, and cardiotrophin-1 and its biotargets in valvular, myocardial, vascular, and renal fibrosis.

Publications

1. Sex‐dependent expression of galectin‐1, a cardioprotective β‐galactoside‐binding lectin, in human calcific aortic stenosis

Journal: The FASEB Journal

Publication Date: 2024-02-15

DOI: 10.1096/fj.202301832rr

ISSN: 0892-6638, 1530-6860

2. Albumin Redox Modifications Promote Cell Calcification Reflecting the Impact of Oxidative Status on Aortic Valve Disease and Atherosclerosis

Journal: Antioxidants

Publication Date: 2024-01

DOI: 10.3390/antiox13010108

3. Coagulation Profile: Alterations and Diagnostic Yield in Pediatric Acute Appendicitis. A Prospective Validation Study

Journal: Surgical Infections

Publication Date: 2023

4. Combined Dapagliflozine And Eplerenone Treatment Improve Cardiorenal Function In Rats With Chronic Kidney Disease

Journal: Hypertension

Publication Date: 2023

5. Correction to: Leucine-Rich Alpha-2-Glycoprotein as a non-invasive biomarker for pediatric acute appendicitis: a systematic review and meta-analysis

Journal: European Journal of Pediatrics

Publication Date: 2023

6. Correction: Diagnostic performance of serum pentraxin-3 in pediatric acute appendicitis: a prospective diagnostic validation study

Journal: Pediatric Surgery International

Publication Date: 2023

7. Diagnostic performance of calprotectin and APPY-1 test in pediatric acute appendicitis: a systematic review and a meta-analysis

Journal: European Journal of Trauma and Emergency Surgery

Publication Date: 2023

8. Diagnostic performance of serum pentraxin-3 in pediatric acute appendicitis: a prospective diagnostic validation study

Journal: Pediatric Surgery International

Publication Date: 2023

9. Flow cytometric characterization of cecal appendix lymphocyte subpopulations in children: a pilot study

Journal: Pediatric Surgery International

Publication Date: 2023

10. Heart valve diseases: from molecular mechanisms to clinical implications

Journal: Frontiers in Molecular Medicine

Publication Date: 2023

11. Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach

Journal: Cardiovascular Diabetology

Publication Date: 2023

 

 

Johannes Bickenbach – Medicine- Best Scholar  – Award Winner 2023

Posted on by Academic achievements
Congratulations to Johannes Bickenbach - Medicine- Best Scholar  - Award Winner 2023

Dr. med. Johannes Bickenbach:

Dr. med. Johannes Bickenbach's career is marked by a rich academic background, clinical expertise, and significant contributions to research and medical science, making him a prominent figure in the field of Anästhesiologie and Intensivmedizin. His leadership roles and ongoing projects underscore his commitment to advancing medical knowledge and improving patient care.

professional profile:

Education:

  • Studium (1994-2001):
    • Studium der Humanmedizin, Medizinische Fakultät der RWTH Aachen
    • Abschluss: III. Staatsexamen (04/2001)

Professional Qualifications:

  • Arzt im Praktikum und Assistenzarzt (07/2001-10/2006):
    • Klinik für Anästhesie, Universitätsklinikum RWTH Aachen
  • Facharzt für Anästhesiologie (10/2006):
  • Zusatzqualifikationen:
    • Transösophagealen Echokardiographie, Hygienebeauftragter Arzt, Medizindidaktik, Leadership, Arzneimittelkommission

Academic Achievements:

  • Dr. med. (15. Januar 2003):
    • Dissertation: "Hochfrequenz-Oszillation im experimentell induzierten Lungenversagen: Effekte auf den Gasaustausch."
  • Habilitation (08.05.2012):
    • Venia legendi für das Fach Anästhesiologie und Intensivmedizin.
  • Außerplanmäßige Professur (20.5.2019):
  • Continuous Supervision of Doctoral Candidates (Since 2006):

Research Activities:

  • Experimental and Clinical Research (Since 2003):
    • Focus on Anästhesiologie and Intensivmedizin.
  • ARDS Research (Since 2007):
    • Implementation of various methods, including lung injury models, MIGET, EIT, and neurohistopathological studies.
  • Weaning Studies (Since 2013):
    • Investigation of characteristics and predictors in patients in prolonged weaning, using various techniques.
  • Current Research Projects (Since 2018):
    • EITTT - Elektrische Impedanztomographie bei Thoraxtrauma, and others.

Clinical Trials:

  • Prüfarzttätigkeit (Since 2007):
    • Participation in various clinical studies, including MAXSEP, HYPRESS, ACEmeVent, PHOENIX, SISPCT, LoveMI, GENIUS.

Leadership Roles:

  • Leitender Oberarzt (Since 09/2016):
    • Klinik für Operative Intensivmedizin und Intermediate Care, Universitätsklinikum RWTH Aachen.
  • Sprecher der AG "AI Zert" (Since 2020):
    • Scientific Working Group on Intensivmedizin der DGAI.

Current Projects and Future Contributions:

  • Active Participation in SMITH Consortium (Since 2017 and 2021):
    • Smart Medical Information Technology for Healthcare, Förderkonzept Medizininformatik des Bundesministeriums für Bildung und Forschung.
  • Project Lead and Principal Investigator (Since 2022):
    • Cross-consortia use case AID4ICU: AI-based early prospective diagnoses of organ failure for ICU patients.

Notable Publication:

Effects of structured protocolized physical therapy on the duration of mechanical ventilation in patients with prolonged weaning. 2023 Dec 1:80:154491

Haemoglobin value and red blood cell transfusions in prolonged weaning from mechanical ventilation: a retrospective observational study. 2022 Jun;9(1):e001228.

Differences between prolonged weaning patients from medical and surgical intensive care units. 2016 Oct;60(9):1270-80

Electrical impedance tomography for predicting failure of spontaneous breathing trials in patients with prolonged weaning. 2017 Jul 12;21(1)

Impact of multidrug-resistant bacteria on outcome in patients with prolonged weaning. 2018 Aug 20;18(1)

Weaning from invasive ventilation : Challenges in the clinical routine. 2022 Dec;71(12)